Bellicum Pharmaceuticals, Inc. Gains 79.59%
Wed, Jun 07, 2023 at 07:53 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) shot up at $0.44, representing a gain of 79.6%. From Wed, May 24, 2023, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Mon, May 08, 2023 at $1.31 with a volume of 100M+.
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- MGO Global Inc. (MGOL:NASDAQ), 84.8%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 79.59%
- Farmer Bros. Co. (FARM:NASDAQ), 70.47%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 54.3%
- Yext, Inc. (YEXT:NYSE), 38.44%
- Leafly Holdings Inc. (LFLY:NASDAQ), 33.17%
- SRAX, Inc. (SRAX:NASDAQ), 31.29%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 29.17%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 28.81%
- Stitch Fix, Inc. (SFIX:NASDAQ), 27.99%